drugset / Trial / NCT01113320
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Approximately twenty four (24) subjects will participate in this research trial. The research trial will be conducted in approximately twelve (12) medical centers in the following countries: Germany, France, South Africa, Austria and Canada. The research trial will last until December 2011.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-11
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Safinamide | Small molecule | 300 mg | — |